327 related articles for article (PubMed ID: 28314270)
1. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
[TBL] [Abstract][Full Text] [Related]
2. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
3. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
Zhang S; Lai N; Liao K; Sun J; Lin Y
Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.
Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O
Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344
[TBL] [Abstract][Full Text] [Related]
7. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells.
Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R
PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
Ahir BK; Ozer H; Engelhard HH; Lakka SS
Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
[TBL] [Abstract][Full Text] [Related]
10. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
11. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
12. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy.
Zheng W; Chen Q; Wang C; Yao D; Zhu L; Pan Y; Zhang J; Bai Y; Shao C
Mol Carcinog; 2020 Jun; 59(6):651-660. PubMed ID: 32253787
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4.
Guo P; Yu Y; Tian Z; Lin Y; Qiu Y; Yao W; Zhang L
Int J Oncol; 2018 Oct; 53(4):1591-1600. PubMed ID: 30066909
[TBL] [Abstract][Full Text] [Related]
15. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
[TBL] [Abstract][Full Text] [Related]
16. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of microRNAs in postoperative radiotherapy sensitive and resistant patients with glioblastoma multiforme.
Wu HM; Wang HD; Tang Y; Fan YW; Hu YB; Tohti M; Hao XK; Wei WT; Wu Y
Tumour Biol; 2015 Jun; 36(6):4723-30. PubMed ID: 25758051
[TBL] [Abstract][Full Text] [Related]
19. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Nayak S; Aich M; Kumar A; Sengupta S; Bajad P; Dhapola P; Paul D; Narta K; Purkrait S; Mehani B; Suri A; Chakraborty D; Mukhopadhyay A; Sarkar C
Sci Rep; 2018 May; 8(1):7673. PubMed ID: 29769662
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]